Archives

by in
Entry Author Date Location
Alnylam Lays Out 2015 Goals 01/06/11 Boston
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive 12/20/10 Seattle
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi 12/06/10 Boston
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine 11/30/10 Detroit
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared 11/17/10 San Francisco
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News 10/27/10 Boston
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal 10/21/10 Boston
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package 09/28/10 Detroit
Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends 09/23/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News 08/13/10 Boston
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs 08/11/10 Boston
Marina Gets RNAi Delivery Tools for $5M 07/28/10 Seattle
Tekmira Nails $140M Defense Contract to Make RNAi Drug for Ebola 07/15/10 Seattle
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Drop the Incrementalism & More Advice on How to Create a Stable Hub for Innovation 07/02/10 San Francisco
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
Modumetal Closes Series B, TerraPower Pulls In $35M, Vertafore Bought for $1.4B, & More Seattle-Area Deals News 06/15/10 Seattle
Polaris Venture Partners Captures $233M of $400M Fund 06/14/10 Boston
Page 3 of 8 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.